Monthly Stock Report: DaVita Inc. (DVA)
Publication Date: September 22, 2024
Company Overview
DaVita Inc. (DVA) stands out in the healthcare sector as a leading provider in the medical care facilities industry, specifically offering kidney dialysis services for patients with chronic kidney failure. Established in 1979 and headquartered in Denver, Colorado, DaVita delivers a diverse range of services, including outpatient dialysis centers, hemodialysis, clinical laboratory services, and integrated care management. The company’s commitment to comprehensive kidney care is evident in its expansion into acute inpatient dialysis and transplant software solutions designed for End-Stage Renal Disease (ESRD) patients. Currently, the medical care facilities industry is undergoing evaluation, with a cautious investment recommendation suggesting a ‘hold’ strategy as investors monitor market conditions. DaVita’s impressive total revenue, reported at approximately $12.52 billion, along with a target high price of $175.00, indicates a positive long-term outlook for potential investors.
Key Financial Insights
DaVita Inc. has a total of 83.9 million shares outstanding, with approximately 5.17 million shares shorted, representing 11.12% of the company’s float. This short interest indicates a moderate level of skepticism among investors, which could lead to increased volatility if short positions require covering. Currently priced at $164.00, the stock is navigating towards its target high of $175.00, with an average target mean price of $155.86 and a median price of $150.00. Analysts maintain a neutral stance with a recommendation average of 3.0, reflecting a balanced outlook among seven contributing analysts. Notably, the stock has fluctuated significantly over the past year, achieving a high of $166.04 and a low of $71.51, underscoring the volatility in this market segment.
Market Sentiment and Moving Averages
The current stock price of $164.00 is just below its fifty-two week high, demonstrating robust performance. The stock’s fifty-day moving average stands at $147.454, reinforcing the trend of upward momentum leading to the current trading level. Overall, market sentiment appears bullish as DaVita approaches its yearly peak, suggesting that both short-term fluctuations and long-term growth opportunities exist for potential investors. With cautious yet constructive recommendations prevailing, the smart investment strategy would involve staying informed and prepared to adjust positions based on evolving market conditions.
| Metric | Value |
|---|---|
| Market Cap | $13.8b |
| Total Debt | $11.7b |
| Total Cash | $437.2m |
| Shares Outstanding | 83.9m |
| Float Shares | 44.2m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.